Skip to main content

Release not found

This press release isn’t in the live store anymore. Open the original on the wire, or jump into the live feed.

Go to feed
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Severe Alopecia Areata · PR Newswire (US) · PPN World